| Targetable genetic features of primary testicular and primary central nervous system lymphomas B Chapuy, MGM Roemer, C Stewart, Y Tan, RP Abo, L Zhang, AJ Dunford, ... Blood, The Journal of the American Society of Hematology 127 (7), 869-881, 2016 | 525 | 2016 |
| Mechanisms and therapeutic implications of hypermutation in gliomas M Touat, YY Li, AN Boynton, LF Spurr, JB Iorgulescu, CL Bohrson, ... Nature 580 (7804), 517-523, 2020 | 456 | 2020 |
| Ascl1 and Neurog2 form novel complexes and regulate Delta-like3 (Dll3) expression in the neural tube RM Henke, DM Meredith, MD Borromeo, TK Savage, JE Johnson Developmental biology 328 (2), 529-540, 2009 | 165 | 2009 |
| Transcriptional autoregulation controls pancreatic Ptf1a expression during development and adulthood T Masui, GH Swift, MA Hale, DM Meredith, JE Johnson, RJ MacDonald Molecular and cellular biology, 2008 | 113 | 2008 |
| A transcription factor network specifying inhibitory versus excitatory neurons in the dorsal spinal cord MD Borromeo, DM Meredith, DS Castro, JC Chang, KC Tung, F Guillemot, ... Development 141 (14), 2803-2812, 2014 | 104 | 2014 |
| Molecular and clinicopathologic features of gliomas harboring NTRK fusions M Torre, V Vasudevaraja, J Serrano, M DeLorenzo, S Malinowski, ... Acta Neuropathologica Communications 8, 1-14, 2020 | 98 | 2020 |
| Prdm13 mediates the balance of inhibitory and excitatory neurons in somatosensory circuits JC Chang, DM Meredith, PR Mayer, MD Borromeo, HC Lai, YH Ou, ... Developmental cell 25 (2), 182-195, 2013 | 73 | 2013 |
| Neurog2 is a direct downstream target of the Ptf1a-Rbpj transcription complex in dorsal spinal cord RM Henke, TK Savage, DM Meredith, SM Glasgow, K Hori, J Dumas, ... Development 136 (17), 2945-2954, 2009 | 66 | 2009 |
| Individualized screening trial of innovative glioblastoma therapy (INSIGhT): a Bayesian adaptive platform trial to develop precision medicines for patients with glioblastoma BM Alexander, L Trippa, S Gaffey, IC Arrillaga-Romany, EQ Lee, ... JCO Precision Oncology 3, 1-13, 2019 | 63 | 2019 |
| Multiple transcriptional mechanisms control Ptf1a levels during neural development including autoregulation by the PTF1-J complex DM Meredith, T Masui, GH Swift, RJ MacDonald, JE Johnson Journal of Neuroscience 29 (36), 11139-11148, 2009 | 53 | 2009 |
| Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results WL Bi, L Nayak, DM Meredith, J Driver, Z Du, S Hoffman, Y Li, EQ Lee, ... Neuro-oncology 24 (1), 101-113, 2022 | 51 | 2022 |
| Program specificity for Ptf1a in pancreas versus neural tube development correlates with distinct collaborating cofactors and chromatin accessibility DM Meredith, MD Borromeo, TG Deering, BH Casey, TK Savage, ... Molecular and cellular biology 33 (16), 3166-3179, 2013 | 38 | 2013 |
| Recurrent EP300-BCOR Fusions in Pediatric Gliomas With Distinct Clinicopathologic Features M Torre, DM Meredith, A Dubuc, DA Solomon, A Perry, V Vasudevaraja, ... Journal of Neuropathology & Experimental Neurology 78 (4), 305-314, 2019 | 35 | 2019 |
| Quantification of aneuploidy in targeted sequencing data using ASCETS LF Spurr, M Touat, AM Taylor, AM Dubuc, J Shih, DM Meredith, ... Bioinformatics 37 (16), 2461-2463, 2021 | 27 | 2021 |
| Chondromyxoid fibroma arising in craniofacial sites: a clinicopathologic analysis of 25 cases DM Meredith, CDM Fletcher, VY Jo The American Journal of Surgical Pathology 42 (3), 392-400, 2018 | 23 | 2018 |
| Immune profiling of pituitary tumors reveals variations in immune infiltration and checkpoint molecule expression Y Mei, WL Bi, J Agolia, C Hu, AM Giantini Larsen, DM Meredith, ... Pituitary 24, 359-373, 2021 | 21 | 2021 |
| SMARCE1 deficiency generates a targetable mSWI/SNF dependency in clear cell meningioma R St. Pierre, CK Collings, DD Samé Guerra, CJ Widmer, O Bolonduro, ... Nature genetics 54 (6), 861-873, 2022 | 20 | 2022 |
| A pilot study of axicabtagene ciloleucel (axi-cel) for the treatment of relapsed/refractory primary and secondary central nervous system lymphoma (CNSL) CA Jacobson, C Falvey, R Bouvier, S Hogan, E Kendricken, J Jones, ... Blood 140 (Supplement 1), 1060-1061, 2022 | 19 | 2022 |
| Clinical utility of targeted next-generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-making MJ Lim-Fat, GC Youssef, M Touat, JB Iorgulescu, S Whorral, M Allen, ... Neuro-oncology 24 (7), 1140-1149, 2022 | 18 | 2022 |
| Loss of histone H3 trimethylation on lysine 27 and nuclear expression of transducin‐like enhancer 1 in primary intracranial sarcoma, DICER1‐mutant S Alexandrescu, DM Meredith, HG Lidov, R Alaggio, M Novello, KL Ligon, ... Histopathology 78 (2), 265-275, 2021 | 18 | 2021 |
